SYED SADATH HUSSAINI ROLL NO : 156

 1. Therapeutic window for stroke : Current guidelines for the management of patients with acute ischemic stroke published by the American Heart Association Stroke Council include specific recommendations for the administration of intravenous recombinant tissue plasminogen activator (rtPA). rtPA should be administered to eligible patients who can be treated in the   time period of 3 to 4.5   hours after stroke. (Evedenced by A recent prospective study, the European Cooperative Acute Stroke Study has provided new data on rtPA (alteplase) treatment in the 3-to-4.5–hour window). 2. Fibrinolytic therapy Thrombolytic medications are delivered to the blood clot through an IV line or a catheter placed in your vein. The thrombolytic therapy drugs in use today are: - Alteplase. - Reteplase. - Tenecteplase. anticoagulants such as warfarin  or heparin  to reduce the risk of future blood clots are also given. 3. Frontal lobe function tests : Tests for frontal lobe function include working

This is an online e log book to discuss our patient de-identified health data shared after taking his / her / guardians signed informed consent. Here we discuss our individual patients problems through series of inputs from available global online community of experts with an aim to solve those patients clinical problem with collective current best evident based input. This E blog also reflects my patient centered online learning portfolio and your valuable inputs on the comment box is welcome. I have been given this case to solve in an attempt to understand the topic of " patient clinical data analysis" to develop my competency in reading and comprehending clinical data including history, clinical findings, investigations and come up with diagnosis and treatment plan. Patient and his/her attenders have been informed and their consent has been taken. 65 yr old female was brought to the casualty with complaints of Difficulty in moving upper limbs and lower limbs since 3 days